摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-bromo-N-methylquinoline-2-carboxamide

中文名称
——
中文别名
——
英文名称
6-bromo-N-methylquinoline-2-carboxamide
英文别名
——
6-bromo-N-methylquinoline-2-carboxamide化学式
CAS
——
化学式
C11H9BrN2O
mdl
——
分子量
265.109
InChiKey
WKMODACSGPPIMN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    42
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    N-甲基甲酰胺6-溴喹啉 在 dipotassium peroxodisulfate 作用下, 反应 12.0h, 以74%的产率得到6-bromo-N-methylquinoline-2-carboxamide
    参考文献:
    名称:
    Transition-metal-free synthesis of primary to tertiary carboxamides: A quick access to prodrug-pyrazinecarboxamide
    摘要:
    One-pot expedient and direct carbamoylation of heterocyclics is described. The transformation is realized via direct dehydrogenative aminocarbonylation of heterocyclic compounds under transition-metal-free conditions. This method is regioselective and the protocol is proved to be scalable on a gram scale. Further, the therapeutically useful antitubercular agent pyrazinecarboxamide is successfully synthesized by employing this protocol. (C) 2017 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2017.11.006
点击查看最新优质反应信息

文献信息

  • [EN] PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATONS<br/>[FR] COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE LA DOULEUR ET D'AUTRES INDICATIONS
    申请人:MERCK SHARP & DOHME
    公开号:WO2011094209A1
    公开(公告)日:2011-08-04
    The present invention is directed to a composition useful for the treatment of a FAAH mediated disease, disorder or conditions comprising a FAAH inhibitor and a second activation, comprising a selected imidazole or oxazole FAAH inhibitor and a second active agent. The compositions will be useful in the treatment of a wide range of disease, disorder, or conditions including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, and fibromyalgia, as well as acute pain, migraine, sleep disorder, Alzheimer disease, and Parkinson's disease. In another aspect the invention discloses herein is directed to compositions useful in the treatment of neuropathic and nociceptive pain, said compositions comprising etoricoxib.
  • Transition-metal-free synthesis of primary to tertiary carboxamides: A quick access to prodrug-pyrazinecarboxamide
    作者:Trimbak B. Mete、Ankit Singh、Ramakrishna G. Bhat
    DOI:10.1016/j.tetlet.2017.11.006
    日期:2017.12
    One-pot expedient and direct carbamoylation of heterocyclics is described. The transformation is realized via direct dehydrogenative aminocarbonylation of heterocyclic compounds under transition-metal-free conditions. This method is regioselective and the protocol is proved to be scalable on a gram scale. Further, the therapeutically useful antitubercular agent pyrazinecarboxamide is successfully synthesized by employing this protocol. (C) 2017 Elsevier Ltd. All rights reserved.
查看更多